Exelixis
Engin Ayturk is a highly experienced professional in the field of process development and manufacturing, currently serving as Senior Director of CMC BioConjugation Process Development & Manufacturing at Exelixis since September 2023. Prior to this role, Ayturk held various leadership positions at Mersana Therapeutics from September 2018 to September 2023, including Executive Director of CMC Process Engineering and BioConjugation Development and Director of CMC Process Engineering & BioConjugation. Ayturk also contributed to Biogen as Senior Manager for Technical Development, overseeing purification and bioseparation development for biologics programs, and was a Senior R&D Manager at Pall Corporation, leading innovative bioprocess technology development. Ayturk's academic background includes a PhD in Chemical Engineering from Worcester Polytechnic Institute and both M.Sc. and B.Sc. degrees in Chemical Engineering from Middle East Technical University.
This person is not in any teams
This person is not in any offices
Exelixis
15 followers
Exelixis strives to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future.